Back to Journals » Clinical Ophthalmology » Volume 4
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,622 | Dovepress* | 9,622+ | 2,021 | 11,643 | |
Totals | 9,622 | 2,021 | 11,643 | ||
*Since 8 April 2010 +Since July 2016 |
View citations on Google Scholar